...
首页> 外文期刊>Methods and Protocols >A Simple and Reliable Protocol for the Preparation and Culturing of Fresh Surgically Resected Human Glioblastoma Tissue
【24h】

A Simple and Reliable Protocol for the Preparation and Culturing of Fresh Surgically Resected Human Glioblastoma Tissue

机译:一种简单可靠的方案,用于制备和培养新鲜手术切除人胶质母细胞瘤组织

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Glioblastoma is a heterogeneous glial cell malignancy with extremely high morbidity and mortality. Current treatment is limited and provide minimal therapeutic efficacy. Previous studies were reliant on cell lines that do not accurately reflect the heterogeneity of the glioma microenvironment. Developing reliable models of human glioblastoma is therefore essential. Direct culture of human brain tumours is often difficult and there is a limited number of protocols available. Hence, we have developed an effective method for the primary culture of human glioblastoma samples obtained during surgical resection. Culturing tumour tissue direct from human brain is advantageous in that cultures (1) more closely resemble true human disease, relative to the use of cell lines; (2) comprise a range of cellular components present in the natural tumour microenvironment; and (3) are free of added antibodies and reagents. Additionally, primary glioblastoma cultures are valuable in studies examining the effects of anti-cancer pharmaceuticals and therapeutic agents, and can be further used in live cell imaging, immunocytochemistry, flow cytometry and immunoassay experiments. Via this protocol, cells are maintained in supplemented medium at 37 °C (5% CO2) and are expected to achieve sufficient confluency within 7 days of initial culture.
机译:胶质母细胞瘤是一种异质神经胶质细胞恶性肿瘤,其发病率极高和死亡率。目前的处理是有限的,提供最小的治疗效果。以前的研究依赖于不准确反映胶质瘤微环境的异质性的细胞系。因此,人类胶质母细胞瘤的开发可靠模型是必不可少的。人脑肿瘤的直接培养通常很困难,可提供有限数量的协议。因此,我们开发了一种有效的方法,用于在手术切除期间获得的人胶质母细胞瘤样品的原发性培养方法。培养来自人脑的肿瘤组织是有利的,培养物(1)相对于使用细胞系的使用更紧密类似于真正的人类疾病; (2)包括在天然肿瘤微环境中存在的一系列细胞组分; (3)没有添加抗体和试剂。另外,原发性胶质母细胞瘤培养物在研究抗癌药物和治疗剂的影响的研究中是有价值的,并且可以进一步用于活细胞成像,免疫细胞化学,流式细胞术和免疫测定实验中。通过该方案,将细胞保持在37℃(5%CO 2)的补充培养基中,并且预期在初始培养的7天内获得足够的汇合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号